Abstract
Using localized NMR spectroscopy on immobilized targets provides us with a method to simultaneously assess binding of small molecules to two different samples. This Target Immobilized NMR Screening (TINS) has a number of advantages, not least is the requirement for minimal quantities of non-isotopically labeled protein and the applicability to insoluble or unstable targets. The technique is sensitive to binding with KD values in the range of 100 nM to 20 mM, while careful selection of the reference protein reduces the number of false positive hits. This combination ensures a maximal number of valid hits from which to select starting points for hit elaboration projects. Hits can be prioritized using biological assays when appropriate, as well as an array of biophysical techniques. So far a variety of soluble proteins, including kinases, GTPases, viral targets and proteases, as well as a membrane protein, have been successfully screened against our fragment library. Here we illustrate our experiences with a number of examples which emphasize the usefulness of the method in selecting and prioritizing fragment hits for elaboration towards leads.
Keywords: Fragment Screening, NMR, protein immobilization, hit validation
Current Topics in Medicinal Chemistry
Title: Target Immobilization and NMR Screening of Fragments in Early Drug Discovery
Volume: 9 Issue: 18
Author(s): Gregg Siegal and Johan G. Hollander
Affiliation:
Keywords: Fragment Screening, NMR, protein immobilization, hit validation
Abstract: Using localized NMR spectroscopy on immobilized targets provides us with a method to simultaneously assess binding of small molecules to two different samples. This Target Immobilized NMR Screening (TINS) has a number of advantages, not least is the requirement for minimal quantities of non-isotopically labeled protein and the applicability to insoluble or unstable targets. The technique is sensitive to binding with KD values in the range of 100 nM to 20 mM, while careful selection of the reference protein reduces the number of false positive hits. This combination ensures a maximal number of valid hits from which to select starting points for hit elaboration projects. Hits can be prioritized using biological assays when appropriate, as well as an array of biophysical techniques. So far a variety of soluble proteins, including kinases, GTPases, viral targets and proteases, as well as a membrane protein, have been successfully screened against our fragment library. Here we illustrate our experiences with a number of examples which emphasize the usefulness of the method in selecting and prioritizing fragment hits for elaboration towards leads.
Export Options
About this article
Cite this article as:
Siegal Gregg and Hollander G. Johan, Target Immobilization and NMR Screening of Fragments in Early Drug Discovery, Current Topics in Medicinal Chemistry 2009; 9 (18) . https://dx.doi.org/10.2174/156802609790102400
DOI https://dx.doi.org/10.2174/156802609790102400 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Adaptogens—History and Future Perspectives
Adaptogens are pharmacologically active compounds or plant extracts that are associated with the ability to enhance the body’s stability against stress. The intake of adaptogens is associated not only with a better ability to adapt to stress and maintain or normalise metabolic functions but also with better mental and physical ...read more
Addressing the Most Common Causes of Death with Niacin/NAD and Inositol Polyphosphates
The most common causes of death in the world are cardiovascular disease (CVD) and cancer. These are perhaps best addressed by reducing lipodystrophy and blockages with niacin and inositol polyphosphates (e.g., IP6+inositol) respectively when addressing CVD. Niacin serves as a vitamin by virtue of its role as a skeletal precursor ...read more
AlphaFold in Medicinal Chemistry: Opportunities and Challenges
AlphaFold, a groundbreaking AI tool for protein structure prediction, is revolutionizing drug discovery. Its near-atomic accuracy unlocks new avenues for designing targeted drugs and performing efficient virtual screening. However, AlphaFold's static predictions lack the dynamic nature of proteins, crucial for understanding drug action. This is especially true for multi-domain proteins, ...read more
Artificial intelligence for Natural Products Discovery and Development
Our approach involves using computational methods to predict the potential therapeutic benefits of natural products by considering factors such as drug structure, targets, and interactions. We also employ multitarget analysis to understand the role of drug targets in disease pathways. We advocate for the use of artificial intelligence in predicting ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Caspase Inhibitors: A Pharmaceutical Industry Perspective
Current Topics in Medicinal Chemistry Choice of Biologic Therapy for Patients with Rheumatoid Arthritis: The Infection Perspective
Current Rheumatology Reviews Medical Image Processing based on Generative Adversarial Networks: A Systematic Review
Current Medical Imaging Technological, Biochemical and Microbiological Evaluation of Dehydrated <i>Pleurotus ostreatus</i> Powder for Nutraceutical Applications
Current Nutrition & Food Science Open Source Software and Web Services for Designing Therapeutic Molecules
Current Topics in Medicinal Chemistry Vertebrae Segmentation in 3D CT Data: A Review of Methods and Evaluation Approaches
Current Medical Imaging Gene Therapy for Parkinsons and Alzheimers Diseases: from the Bench to Clinical Trials
Current Pharmaceutical Design Nanotechnology-based Approaches and Investigational Therapeutics against COVID-19
Current Pharmaceutical Design Risk Factors Identification and Prediction of Anemia among Women in Bangladesh using Machine Learning Techniques
Current Women`s Health Reviews Efflux Pumps of Gram-Negative Bacteria, a New Target for New Molecules
Current Topics in Medicinal Chemistry Recent Advances in Developing K-Ras Plasma Membrane Localization Inhibitors
Current Topics in Medicinal Chemistry Computational Models for Central Nervous System Penetration
Current Computer-Aided Drug Design Learning from the <i>In Vitro</i> Biological Activity Data of Current Antiviral Medicines for the Successful Development of New Antiviral Drug Candidates
Letters in Drug Design & Discovery Synthesis and Antimicrobial Activity of Thiohydantoins Obtained from L-Amino Acids
Letters in Drug Design & Discovery Clinical Trials for Acute Kidney Injury: Design Challenges and Possible Solutions
Current Drug Targets Safety and Monitoring of the Treatment with Disease-Modifying Therapies (DMTs) for Multiple Sclerosis (MS)
Current Reviews in Clinical and Experimental Pharmacology Menstrual Blood-Derived Mesenchymal Stem Cell Therapy for Severe COVID-19 Patients
Current Stem Cell Research & Therapy Materials Degradation in PVC Medical Devices, DEHP Leaching and Neonatal Outcomes
Current Medicinal Chemistry Targeting DNA Minor Groove by Hybrid Molecules as Anticancer Agents
Current Medicinal Chemistry COVID-19 and Alzheimer's Disease: Neuroinflammation, Oxidative Stress, Ferroptosis, and Mechanisms Involved
Current Medicinal Chemistry